文献速递呼吸衰竭与机械通气儿科与产科急症

婴幼儿毛细支气管炎高流量氧疗随机试验

A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis.
PubMed 文献 · N Engl J Med · 2018-01-01
一句话结论在ICU外治疗的毛细支气管炎婴儿中,经鼻导管高流量氧疗较标准氧疗显著降低因治疗失败而升级治疗的比例(12% vs 23%)。

这项多中心随机对照试验纳入1472例小于12月龄、因毛细支气管炎需要补充氧疗的婴儿,比较经鼻导管高流量氧疗与标准氧疗。主要终点为因治疗失败而升级治疗(满足持续心动过速、呼吸急促、低氧血症、医院早期预警工具触发的医疗评估4项临床标准中≥3项)。高流量组升级治疗比例为12%(87/739),标准氧疗组为23%(167/733),风险差-11个百分点(95%CI -11至-7,P<0.001)。两组住院时间、氧疗时间无显著差异,每组各发生1例气胸(<1%);标准氧疗组167例治疗失败者中102例(61%)对高流量补救治疗有反应。

要点

  • 在ICU外治疗的毛细支气管炎婴儿中,高流量氧疗组因治疗失败升级治疗的比例为12%(87/739),标准氧疗组为23%(167/733),风险差-11个百分点(95%CI -15至-7,P<0.001)。
  • 高流量氧疗组与标准氧疗组的住院时间、氧疗时间无显著差异。
  • 两组气胸发生率均<1%(每组各1例)。
  • 标准氧疗组167例治疗失败婴儿中,102例(61%)对高流量补救治疗有反应。

适用人群与场景

  • 小于12月龄、诊断为毛细支气管炎且需要补充氧疗的婴儿,在ICU外(普通病房)治疗。

诊断标准与关键阈值

  • 治疗失败定义为满足以下4项临床标准中≥3项:持续心动过速、呼吸急促、低氧血症、医院早期预警工具触发的医疗评估。

处置流程与药物剂量

  • 高流量组接受经鼻导管高流量氧疗;标准氧疗组接受标准氧疗,若病情符合治疗失败标准可接受高流量补救治疗。

红旗征与不能漏的情况

  • 满足治疗失败标准(持续心动过速、呼吸急促、低氧血症、医院早期预警工具触发的医疗评估中≥3项)需升级治疗。

研究设计与关键结果

  • 多中心随机对照试验,纳入1472例婴儿;高流量组升级治疗比例12%(87/739)vs 标准氧疗组23%(167/733),风险差-11个百分点(95%CI -15至-7,P<0.001)。
  • 住院时间、氧疗时间两组无显著差异;每组各1例气胸(<1%);标准氧疗组167例治疗失败者中102例(61%)对高流量补救治疗有反应。

证据类型、等级与局限

  • 研究类型:多中心随机对照试验;样本量1472例;主要终点结果见results。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在ICU外治疗的需要补充氧疗的毛细支气管炎婴儿中,高流量氧疗可降低因治疗失败而升级治疗的风险;标准氧疗组治疗失败者中61%对高流量补救治疗有反应。

指南或共识出处

  • Australian and New Zealand Clinical Trials Registry number, ACTRN12613000388718;资助:National Health and Medical Research Council and others。

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: High-flow oxygen therapy through a nasal cannula has been increasingly used in infants with bronchiolitis, despite limited high-quality evidence of its efficacy. The efficacy of high-flow oxygen therapy through a nasal cannula in settings other than intensive care units (ICUs) is unclear.

METHODS: In this multicenter, randomized, controlled trial, we assigned infants younger than 12 months of age who had bronchiolitis and a need for supplemental oxygen therapy to receive either high-flow oxygen therapy (high-flow group) or standard oxygen therapy (standard-therapy group). Infants in the standard-therapy group could receive rescue high-flow oxygen therapy if their condition met criteria for treatment failure. The primary outcome was escalation of care due to treatment failure (defined as meeting ≥3 of 4 clinical criteria: persistent tachycardia, tachypnea, hypoxemia, and medical review triggered by a hospital early-warning tool). Secondary outcomes included duration of hospital stay, duration of oxygen therapy, and rates of transfer to a tertiary hospital, ICU admission, intubation, and adverse events.

RESULTS: The analyses included 1472 patients. The percentage of infants receiving escalation of care was 12% (87 of 739 infants) in the high-flow group, as compared with 23% (167 of 733) in the standard-therapy group (risk difference, -11 percentage points; 95% confidence interval, -15 to -7; P<0.001). No significant differences were observed in the duration of hospital stay or the duration of oxygen therapy. In each group, one case of pneumothorax (<1% of infants) occurred. Among the 167 infants in the standard-therapy group who had treatment failure, 102 (61%) had a response to high-flow rescue therapy.

CONCLUSIONS: Among infants with bronchiolitis who were treated outside an ICU, those who received high-flow oxygen therapy had significantly lower rates of escalation of care due to treatment failure than those in the group that received standard oxygen therapy. (Funded by the National Health and Medical Research Council and others; Australian and New Zealand Clinical Trials Registry number, ACTRN12613000388718 .).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Franklin D, Babl FE, Schlapbach LJ, et al. A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis. N Engl J Med. 2018. PMID: 29562151. doi:10.1056/NEJMoa1714855

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。